ocrelizumabNatalizumabFingolimodAlemtuzumabmultiple sclerosis
…pse risk (1.35, 1.16 to 1.57) and RAW (1.77, 1.07 to 2.94) than ocrelizumab. Alemtuzumab was associated with higher ARR (0.18 vs 0.12, p<0.…
3articles mentioning drugs
6drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: fingolimod ×
fingolimod
This drug is selected. Its supporting articles are shown below.
Articles mentioning fingolimod
3 articles · page 1 of 1teriflunomidefingolimodinterferon betaglatiramer acetateocrelizumabrituximabdimethyl fumarateRIFUND-MSDMF
…a vs glatiramer acetate), RIFUND-MS (rituximab vs DMF), TENERE (teriflunomide vs interferon beta) and TRANSFORMS (fingolimod vs interferon be…
fingolimodcladribinemonoclonal antibodiesmultiple sclerosisMSHigh-efficacy therapyaggressive MS
…on were compared between those receiving high-efficacy therapy (fingolimod, cladribine, monoclonal antibodies) vs. other/no therapy. Margi…